CLINICAL_TRIALS
research
· 2025-12-15
Clinical Trial Update: INTREPId (INTermediate Risk Erection PreservatIon Trial) [Phase 2]
Summary
A Phase 2 clinical trial (INTREPId) for prostate cancer, focused on erection preservation, is currently not recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Brigham and Women's Hospital | Conditions: Prostate Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING